Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Eti Zigman-Hoffman, Benjamin Sredni, Benjamin Meilik, Ella Naparstek & Boris Tartakovsky. (2021) Tellurium compound provides pro-apoptotic signaling in drug resistant multiple myeloma. Leukemia & Lymphoma 62:5, pages 1146-1156.
Read now
Read now
Wang Li, Lynn T. Frame, Karlene A. Hoo, Yuan Li, Nicholas D'Cunha & Everardo Cobos. (2011) Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro. Leukemia & Lymphoma 52:12, pages 2380-2390.
Read now
Read now
Haiwen Huang, Depei Wu, Jinxiang Fu & Guanghua Chen. (2009) Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid. Leukemia & Lymphoma 50:6, pages 966-973.
Read now
Read now
Judith Schuster-Kolbe, Heinz Ludwig, GÜNther R. Adolf & Karl-Heinz Heider. (1999) Expression of CD44 Isoforms on Isolated Bone Marrow Plasma Cells and Peripheral CD19+ B Cells of Patients with Multiple Myeloma and Healthy Individuals. Leukemia & Lymphoma 34:1-2, pages 95-103.
Read now
Read now
Robert G. Hawley & Lloyd C. Berger. (1998) Growth Control Mechanisms in Multiple Myeloma. Leukemia & Lymphoma 29:5-6, pages 465-475.
Read now
Read now
Ulrich Kaiser, Bernhard Auerbach & Marcus Oldenburg. (1996) The neural cell adhesion molecule NCAM in multiple myeloma. Leukemia & Lymphoma 20:5-6, pages 389-395.
Read now
Read now
Articles from other publishers (32)
Maroun Bou Zerdan, Lewis Nasr, Joseph Kassab, Ludovic Saba, Myriam Ghossein, Marita Yaghi, Barbara Dominguez & Chakra P Chaulagain. (2022) Adhesion molecules in multiple myeloma oncogenesis and targeted therapy. International Journal of Hematologic Oncology 11:2.
Crossref
Crossref
Adam S. Sperling & Kenneth C. Anderson. (2021) Facts and Hopes in Multiple Myeloma Immunotherapy. Clinical Cancer Research 27:16, pages 4468-4477.
Crossref
Crossref
Bibo Ye, Yingying Zhou, Yanli Liu, Xuewei Li, Tianyu Li & Xiaofei Qi. (2021) Pulsatilla saponin A Induces Apoptosis and Differentiation of Myeloma Cells. Anti-Cancer Agents in Medicinal Chemistry 21:7, pages 919-926.
Crossref
Crossref
Daniel W. Sherbenou, Yang Su, Christopher R. Behrens, Blake T. Aftab, Olivia Perez de Acha, Megan Murnane, Shelby C. Bearrows, Byron C. Hann, Jeffery L. Wolf, Thomas G. Martin & Bin Liu. (2020) Potent Activity of an Anti-ICAM1 Antibody–Drug Conjugate against Multiple Myeloma. Clinical Cancer Research 26:22, pages 6028-6038.
Crossref
Crossref
Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Marta Pugliese, Eleonora Di Salvo, Elvira Ventura-Spagnolo, Caterina Musolino & Sebastiano Gangemi. (2019) Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. International Journal of Molecular Sciences 20:11, pages 2822.
Crossref
Crossref
Ralph D. Sanderson, Michael Elkin, Alan C. Rapraeger, Neta Ilan & Israel Vlodavsky. (2016) Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy. The FEBS Journal 284:1, pages 42-55.
Crossref
Crossref
SABNA RAJEEV KRISHNAN, RITU JAISWAL, ROSS D. BROWN, FREDERICK LUK & MARY BEBAWY. (2016) Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review). International Journal of Oncology 49:1, pages 33-50.
Crossref
Crossref
Krzysztof M. Mrozik, Chee Man Cheong, Duncan Hewett, Annie W.S. Chow, Orest W. Blaschuk, Andrew C.W. Zannettino & Kate Vandyke. (2015) Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma. British Journal of Haematology 171:3, pages 387-399.
Crossref
Crossref
Isabelle Vande Broek, Karin Vanderkerken, Benjamin Van Camp & Ivan Van Riet. (2007) Extravasation and homing mechanisms in multiple myeloma. Clinical & Experimental Metastasis 25:4, pages 325-334.
Crossref
Crossref
Masayoshi Kobune, Hiroki Chiba, Junji Kato, Kazunori Kato, Kiminori Nakamura, Yutaka Kawano, Kohichi Takada, Rishu Takimoto, Tetsuji Takayama, Hirofumi Hamada & Yoshiro Niitsu. (2007) Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Molecular Cancer Therapeutics 6:6, pages 1774-1784.
Crossref
Crossref
Gough G. Au, Lisa F. Lincz, Arno Enno & Darren R. Shafren. (2007) Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma. British Journal of Haematology 137:2, pages 133-141.
Crossref
Crossref
Eline Menu, Evy De Leenheer, Hendrik De Raeve, Les Coulton, Takeshi Imanishi, Kazuyuki Miyashita, Els Van Valckenborgh, Ivan Van Riet, Ben Van Camp, Richard Horuk, Peter Croucher & Karin Vanderkerken. (2006) Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clinical & Experimental Metastasis 23:5-6, pages 291-300.
Crossref
Crossref
Eline MenuHelena Jernberg-WiklundThomas StrombergHendrik De RaeveLeonard GirnitaOlle LarssonMagnus AxelsonKewal AsosinghKenneth NilssonBen Van CampKarin Vanderkerken. (2006) Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. Blood 107:2, pages 655-660.
Crossref
Crossref
Jian Hou, Hong Xiong, Weiran Gao & Hua Jiang. (2005) 2-Methoxyestradiol at low dose induces differentiation of myeloma cells. Leukemia Research 29:9, pages 1059-1067.
Crossref
Crossref
Michael G. Alexandrakis, Freda H. Passam, Katerina Sfiridaki, Panayiotis Kafarakis, Elli Karydi, Dimitra Liapi, Kostas Perisinakis & Despina S. Kyriakou. (2004) Clinical significance of circulating endothelial adhesion molecules (sE-selectin and sICAM) in untreated multiple myeloma patients. Clinica Chimica Acta 349:1-2, pages 39-43.
Crossref
Crossref
Eline Menu, Kewal Asosingh, Ivan Van Riet, Peter Croucher, Ben Van Camp & Karin Vanderkerken. (2004) Myeloma cells (5TMM) and their interactions with the marrow microenvironment. Blood Cells, Molecules, and Diseases 33:2, pages 111-119.
Crossref
Crossref
E Menu, R Kooijman, E Van Valckenborgh, K Asosingh, M Bakkus, B Van Camp & K Vanderkerken. (2004) Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. British Journal of Cancer 90:5, pages 1076-1083.
Crossref
Crossref
ELINE MENU, FILIP BRAET, MAARTEN TIMMERS, IVAN RIET, BEN CAMP & KARIN VANDERKERKEN. (2002) The F-Actin Content of Multiple Myeloma Cells as a Measure of Their Migration. Annals of the New York Academy of Sciences 973:1, pages 124-136.
Crossref
Crossref
Hans G. Drexler & Yoshinobu Matsuo. (2000) Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leukemia Research 24:8, pages 681-703.
Crossref
Crossref
Karin VanderkerkenKewal AsosinghFilip BraetIvan Van RietBen Van Camp. (1999) Insulin-Like Growth Factor-1 Acts as a Chemoattractant Factor for 5T2 Multiple Myeloma Cells. Blood 93:1, pages 235-241.
Crossref
Crossref
Judy Faust, Pamela Hunt, Sheila Scully & Victoria Shalhoub. (1998) Multiple myeloma cells and cells of the human osteoclast lineage share morphological and cell surface markers. Journal of Cellular Biochemistry 71:4, pages 559-568.
Crossref
Crossref
Ivan Van Riet, Karin Vanderkerken, Catherine de Greef & Ben Van Camp. (1998) Homing behaviour of the malignant cell clone in multiple myeloma. Medical Oncology 15:3, pages 154-164.
Crossref
Crossref
John A. Lust & Kathleen A. Donovan. (2017) Biology of the Transition of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma. Cancer Control 5:3, pages 209-217.
Crossref
Crossref
G. David Roodman. (1997) Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer 80:S8, pages 1557-1563.
Crossref
Crossref
M.H. Helfrich, E. Livingston, I.M. Franklin & R.L. Soutar. (1997) Expression of adhesion molecules in malignant plasma cells in multiple myeloma: comparison with normal plasma cells and functional significance. Blood Reviews 11:1, pages 28-38.
Crossref
Crossref
Norihiro Nishimoto, Taoamitsu Kishimoto & Sachiko Suematsu. 1997. Advances in Immunology Volume 64. Advances in Immunology Volume 64
219
281
.
L. Faid, I. Van Riet, M. De Waele, T. Facon, R. Schots, P. Lacor & B. Van Camp. (2009) Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma. European Journal of Haematology 57:5, pages 349-358.
Crossref
Crossref
Tomoko Okada & Robert G. Hawley. (1995) Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements. International Journal of Cancer 63:6, pages 823-830.
Crossref
Crossref
Mario Boccadoro & Alessandro Pileri. (1995) 1Plasma cell dyscrasias: classification, clinical and laboratory characteristics, and differential diagnosis. Baillière's Clinical Haematology 8:4, pages 705-719.
Crossref
Crossref
Douglas E. Joshua, Ross D. Brown & John Gibson. (2008) MULTIPLE MYELOMA: WHY DOES THE DISEASE ESCAPE FROM PLATEAU PHASE?. British Journal of Haematology 88:4, pages 667-671.
Crossref
Crossref
Paolo de Paoli, Monica D'Andrea, Gianfranco Santini, Vittorina Zagonel, Antonello Pinto & Antonino Carbone. (1994) Serum levels of adhesion molecules in haematopoietic tumours. Immunology Today 15:7, pages 339.
Crossref
Crossref
D.E. Joshua, J. Gibson & R.D. Brown. (1994) Mechanisms of the escape phase of myeloma. Blood Reviews 8:1, pages 13-20.
Crossref
Crossref